October 23, 2014 The Institute of Medicine (IOM) recently announced 70 new members, four of which are DF/HCC researchers. Membership to the IOM is among the highest... | [more]
Welcome to Dana-Farber/Harvard Cancer CenterDana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.
Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
- Seminars in Oncology: "Biological Insights into EGFR Mutant Lung Cancer" Posted: 11-13-14
- Seminars in Oncology: "Chromatin Regulators As Cancer Dependencies" Posted: 11-05-14
- Seminars in Oncology: "Exploring the Contribution of Cyclin D1 to Neoplastic Development” Posted: 10-30-14
Latest Cancer News
October 2014 | eNewsThis year, 32 Scholars participated in the NCI Continuing Umbrella of Research Experiences (CURE) program, a hands-on research training experience for... | [more]
October 2014 | eNews Franziska Michor, PhD (DFCI), applies mathematical modeling to try to predict how cancers accumulate mutations and other changes and how these... | [more]